Balanced news tone
News Sentiment
EUDA sentiment intelligence
EUDA Health Holdings Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-18.9% over one week, -25.9% over four weeks, trend inactive, and below fair value.
12 Health Care Stocks Moving In Friday's Intraday Session
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
EUDA Health Holdings Limited Regains Compliance with Nasdaq Listing Requirements
EUDA Health Holdings Limited has regained compliance with Nasdaq's listing requirements after maintaining a market value of $35 million or greater for ten consecutive business days. The company, a Singapore-based non-invasive healthcare provider focusing on Singapore, Malaysia, a
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 01 Jun 2026 10:11
- Source
- Quiver Quantitative
EUDA Health Holdings Limited Expands Helixé Product Line with Launch of Regenixé iPSC-derived Skin Stem Cell Secretome Mask
EUDA Health Holdings Limited has expanded its Helixé product line by launching the Regenixé iPSC-derived Skin Stem Cell Secretome Mask, developed by Chemokine Pte Ltd. EUDA holds exclusive global distributorship for this new skincare product, which aims to enhance skin hydration
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Jun 2026 10:11
- Source
- Quiver Quantitative
Stem cell skincare: EUDA targets $8B face mask market with Regenixé
EUDA Health (NASDAQ:EUDA) is expanding its Helixé product line with the launch of the Regenixé iPSC-derived Skin Stem Cell Secretome Mask, developed by Chemokine. EUDA holds exclusive global distributorship rights for Helixé and plans to leverage distribution networks in Malaysia
- Tone
- Positive 67/100
- Event
- Balance sheet
- Published
- 01 Jun 2026 10:05
- Source
- Stock Titan
EUDA Health restores Nasdaq listing compliance after value shortfall
EUDA Health (NASDAQ:EUDA) has regained compliance with Nasdaq's Minimum Market Value of Listed Securities (MVLS) requirement. The company's MVLS was at least $35 million for ten consecutive business days from May 13 to May 27, 2026, after previously receiving a deficiency notice
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 09:59
- Source
- Stock Titan
EUDA Health regains Nasdaq listing compliance
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Investing.com
EUDA - Euda Health Holdings Limited Stock Price and Quote
This article provides detailed stock information for Euda Health Holdings Limited (EUDA), including its current trading price, financial metrics, insider and institutional ownership, and recent performance. It also lists a chronological series of news headlines related to the com
- Tone
- Negative 39/100
- Event
- Market update
- Published
- 27 May 2026 19:10
- Source
- Finviz
EUDA Health (NASDAQ: EUDA) registers 947,963 shares for resale; MVLS notice
EUDA Health Holdings Limited has filed a Form F-3 prospectus to register 947,963 ordinary shares for resale by existing selling shareholders. The company will not receive any proceeds from these sales. The filing also highlights significant risks, including a Nasdaq notice for fa
- Tone
- Negative 37/100
- Event
- Market update
- Published
- 26 May 2026 15:40
- Source
- Stock Titan
Q1 Earnings Outperformers: JLL (NYSE:JLL) And The Rest Of The Consumer Discretionary - Real Estate Services Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 May 2026 07:00
- Source
- Market source
A Look Back at Consumer Discretionary - Real Estate Services Stocks’ Q4 Earnings: Howard Hughes Holdings (NYSE:HHH) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Apr 2026 07:00
- Source
- Market source
EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Apr 2026 10:00
- Source
- GlobeNewswire
EUDA Health Holdings Limited Receives Nasdaq MVLS Notice with 180-Day Compliance Period to Regain Listing Status | EUDA Stock News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Apr 2026 07:00
- Source
- Quiver Quantitative
EUDA Health receives Nasdaq delisting warning over market value
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 27 Apr 2026 07:00
- Source
- Investing.com
A Look Back at Consumer Discretionary - Real Estate Services Stocks’ Q4 Earnings: RE/MAX (NYSE:RMAX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
EUDA Stock Price and Chart — NASDAQ:EUDA
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- TradingView
Consumer Discretionary - Real Estate Services Stocks Q4 Results: Benchmarking Opendoor (NASDAQ:OPEN)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Cushman & Wakefield (NYSE:CWK) In The Context Of Other Consumer Discretionary - Real Estate Services Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: eXp World (NASDAQ:EXPI) Vs The Rest Of The Consumer Discretionary - Real Estate Services Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Apr 2026 07:00
- Source
- Market source
A Look Back at Consumer Discretionary - Real Estate Services Stocks’ Q4 Earnings: Newmark (NASDAQ:NMRK) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Apr 2026 07:00
- Source
- Market source
EUDA Health executes 1-for-20 reverse stock split
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Mar 2026 07:00
- Source
- Investing.com
EUDA Health Holdings Limited Announces 1-for-20 Reverse Stock Split Effective March 23, 2026 | EUDA Stock News
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Mar 2026 07:00
- Source
- Quiver Quantitative
Q4 Consumer Discretionary - Real Estate Services Earnings Review: First Prize Goes to The Real Brokerage (NASDAQ:REAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 15 Mar 2026 07:00
- Source
- StockStory
EUDA Health Holdings Limited Completes Repurchase and Cancellation of Warrant from Streeterville Capital, LLC
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 04 Mar 2026 08:00
- Source
- Quiver Quantitative
Q3 Earnings Outperformers: JLL (NYSE:JLL) And The Rest Of The Real Estate Services Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 Feb 2026 08:00
- Source
- StockStory
Q3 Earnings Highs And Lows: Opendoor (NASDAQ:OPEN) Vs The Rest Of The Real Estate Services Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Jan 2026 08:00
- Source
- Market source
Real Estate Services Stocks Q3 Earnings: Howard Hughes Holdings (NYSE:HHH) Firing on All Cylinders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Jan 2026 08:00
- Source
- Market source
EUDA Health Holdings Limited's (NASDAQ:EUDA) biggest owners are retail investors who got richer after stock soared 28% last week
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Oct 2025 07:00
- Source
- simplywall.st
EUDA Health (EUDA) Stock Forecast and Price Target 2026
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 15 May 2024 05:51
- Source
- MarketBeat
EUDA Health (EUDA) 10K Form and Latest SEC Filings 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jan 2024 12:53
- Source
- MarketBeat
Should I buy EUDA Health Holdings Limited (EUDA)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Nov 2022 02:03
- Source
- Zacks Investment Research